Functional gallbladder and sphincter of oddi disorders

J Behar, E Corazziari, M Guelrud, W Hogan… - Gastroenterology, 2006 - Elsevier
The functional disorder of the gallbladder (GB) is a motility disorder caused initially either by
metabolic abnormalities or by a primary motility alteration. The functional disorders of the …

The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants

…, JP Robinson, AM Tsang, P Switzer, JV Behar… - Journal of exposure …, 2001 - nature.com
Because human activities impact the timing, location, and degree of pollutant exposure, they
play a key role in explaining exposure variation. This fact has motivated the collection of …

Eosinophilic gastroenteritis with esophageal involvement

JW Dobbins, DG Sheahan, J Behar - Gastroenterology, 1977 - Elsevier
A patient with a lifelong history of asthma and hay fever was investigated because of symptoms
of esophageal spasm. Esophageal biopsies revealed elongated papillae and basal zone …

Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis

W Cao, L Cheng, J Behar, C Fiocchi… - American Journal …, 2004 - journals.physiology.org
Cholinergic mechanisms are largely responsible for esophageal contraction in response to
swallowing or to in vitro electrical field stimulation (EFS). After induction of experimental …

Gallbladder contraction in patients with pigment and cholesterol stones

J Behar, KY Lee, WR Thompson, P Biancani - Gastroenterology, 1989 - Elsevier
Thirty gallbladders were studied in vitro; 5 had black pigment stones and 25 contained
manifestations of excess cholesterol in bile. Of the 25, 14 had cholesterol stones, 7 had …

Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity

Q Chen, J Amaral, P Biancani, J Behar - Gastroenterology, 1999 - Elsevier
Background & Aims: The relationship between muscle contractility, plasma membrane
cholesterol, and fluidity was investigated in human gallbladders with gallstones. Methods: …

A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis

RW McCallum, DA Ricci, H Rakatansky, J Behar… - Diabetes …, 1983 - Am Diabetes Assoc
40 patients with diabetic gastroparesis. Results of a 3-wk double-blind study indicate that
metoclopramide at a dosage of one 10-mg tablet four times daily reduced nausea, vomiting, …

Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma

J Hong, J Behar, J Wands, M Resnick, LJ Wang… - Gut, 2010 - gut.bmj.com
Background and aims Mechanisms of the progression from Barrett's oesophagus to oesophageal
adenocarcinoma (OA) are not fully understood. Bile acids may have an important role …

[HTML][HTML] cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells

X Fu, DG Beer, J Behar, J Wands, D Lambeth… - Journal of biological …, 2006 - ASBMB
Gastroesophageal reflux disease complicated by Barrett esophagus (BE) is a major risk
factor for esophageal adenocarcinoma (EA). The mechanisms whereby acid reflux may …

Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones

…, P Cong, M Cicala, R Alloni, S Carotti, J Behar - Gut, 2007 - gut.bmj.com
Objective: To examine the mechanisms of action of ursodeoxycholic acid (UDCA) on
gallbladder (GB) muscle cells in patients with symptomatic cholesterol gallstones (GSs) as it …